Patents by Inventor Mark R. Contarino

Mark R. Contarino has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230355708
    Abstract: The present disclosure relates, in part, to a composition for promoting virolysis and/or inhibition of infection of a vims in a mammal, the composition comprising a lectin mutant. In certain embodiments, the lectin mutant comprises mutant cyanovirin N (CVN) and mutant Griffithsin (GRFT). The present disclosure further provides methods of treating, preventing, and/or ameliorating viral infection in a subject. In certain embodiments, the viral infection is caused by a vims selected from the group consisting of SARS-CoV-1, SARS-CoV-2, and HIV-I. The present disclosure further provides cyclic compounds useful for the treatment, prevention, and/or amelioration of HIV-I in a subject.
    Type: Application
    Filed: September 29, 2021
    Publication date: November 9, 2023
    Inventors: Irwin M. Chaiken, Aakansha Nangarlia, Gabriela Canziani, Cameron Frank Abrams, Adel Ahmed Rashad Ahmed, Mark R. Contarino, Bibek Parajuli
  • Patent number: 9233138
    Abstract: The present invention includes compounds that are useful for treating or preventing a HIV-1 infection in a mammal. In certain embodiments, the compounds cause cell-free virolysis of an HIV-1 virus. The presented invention further includes a method of causing virolysis of a virus using the compounds described therein. The presented invention further includes a method of treating or preventing an HIV-1 infection in a mammal in need thereof using the compositions described therein.
    Type: Grant
    Filed: October 22, 2014
    Date of Patent: January 12, 2016
    Assignee: Drexel University
    Inventors: Cameron Frank Abrams, Irwin M. Chaiken, Mark R. Contarino, Bibek Parajuli, Adel Ahmed Rashad Ahmed
  • Publication number: 20150111814
    Abstract: The present invention includes compounds that are useful for treating or preventing a HIV-1 infection in a mammal. In certain embodiments, the compounds cause cell-free virolysis of an HIV-1 virus. The presented invention further includes a method of causing virolysis of a virus using the compounds described therein. The presented invention further includes a method of treating or preventing an HIV-1 infection in a mammal in need thereof using the compositions described therein.
    Type: Application
    Filed: October 22, 2014
    Publication date: April 23, 2015
    Inventors: Cameron Frank Abrams, Irwin M. Chaiken, Mark R. Contarino, Bibek Parajuli, Adel Ahmed Rashad Ahmed